Reinsurance Group Of America, Incorporated
—- Market cap
- $16.16B
- Debt
- —
- Cash
- −$4.17B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: RGA stock price vs MET: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MET's multiple
Needs MET P/E.
Implied fair value · at RGA's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REINSURANCE GROUP OF AMERICA, INCORPORATED · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
MetLife, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BROWN & BROWN, INC.
RGA vs BRO
HANOVER INSURANCE GROUP, INC.
RGA vs THG
TRAVELERS COMPANIES, INC.
RGA vs TRV
ALLSTATE CORP
RGA vs ALL
EVEREST GROUP, LTD.
RGA vs EG
AFLAC INC
RGA vs AFL
American International Group, Inc.
RGA vs AIG
LINCOLN NATIONAL CORP
RGA vs LNC
HARTFORD FINANCIAL SERVICES GROUP, INC.
RGA vs HIG
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe RGA can sustain its mid-single-digit profitability and convert its lower leverage into earnings durability, then the current level looks attractive versus MET because RGA trades at 11.9x P/E versus MET’s 18.9x while still showing a 58.6% implied upside.
RGA trades at 11.9x P/E versus MET at 18.9x, yet the model implies a fair value of $333.67 versus a current price of $210.45, or 58.6% upside. The relative valuation gap is supported by cheaper earnings and sales multiples, though some market skepticism may reflect incomplete efficiency and cash-flow data.
Supporting Metrics